In Vitro Three‐Dimensional Liver Models for Nanomaterial DNA Damage Assessment
Open accessThe DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Whilst the liver possesses the ability to repair and restore sections of damaged tissue following acute injury, prolonged exposure to engineered nanomaterials (ENM) may induce repetitive injury leading to chronic liver disease. Screening ENM cytotoxicity using 3D liver models has recently been performed, but a significant challenge has been the application of such in vitro models for evaluating ENM associated genotoxicity; a vital component of regulatory human health risk assessment. This review considers the benefits, limitations, and adaptations of specific in vitro approaches to assess DNA damage in the liver, whilst identifying critical advancements required to support a multitude of biochemical endpoints, focusing on nano(geno)toxicology (e.g., secondary genotoxicity, DNA damage, and repair following prolonged or repeated exposures).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pallavi et al. profiled HepG2 spheroids and documented time-dependent attenuation of proliferation coupled with enhanced expression of albumin, CYP450 enzymes, and other hepatospecific markers [213].”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [213]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanomaterials and nanoparticles: Sources and toxicity
Buzea, C., Pacheco, I. I., & Robbie, K. (2007) · Biointerphases · doi:10.1116/1.2815690 · Cited by 3,789
The in vitro micronucleus technique
Fenech, M. (2000) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(00)00065-8 · Cited by 2,510
Cytokinesis-block micronucleus cytome assay
Fenech, M. (2007) · Nature Protocols · doi:10.1038/nprot.2007.77 · Cited by 2,019
The p53 pathway: positive and negative feedback loops
Harris, S. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208615 · Cited by 1,967
Mechanisms of Nanoparticle-Induced Oxidative Stress and Toxicity
Manke, A., Wang, L., & Rojanasakul, Y. (2013) · BioMed Research International · doi:10.1155/2013/942916 · Cited by 1,727
Trefts, E., Gannon, M., & Wasserman, D. H. (2017) · Current Biology · doi:10.1016/j.cub.2017.09.019 · Cited by 1,452
Infection of a human hepatoma cell line by hepatitis B virus
Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C., & Guguen-Guillouzo, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232137699 · Cited by 1,282
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
NanoGenotoxicology: The DNA damaging potential of engineered nanomaterials
Singh, N., Manshian, B., Jenkins, G. J. S., Griffiths, S. M., Williams, P. M., Maffeis, T. G. G., Wright, C. J., & Doak, S. H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.009 · Cited by 1,184
Self-citationRushing, B. R., & Selim, M. I. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.11.047 · Cited by 989
Toxicology of nanoparticles: A historical perspective
Oberdörster, G., Stone, V., & Donaldson, K. (2007) · Nanotoxicology · doi:10.1080/17435390701314761 · Cited by 964
Huang, K., Ma, H., Liu, J., Huo, S., Kumar, A., Wei, T., Zhang, X., Jin, S., Gan, Y., Wang, P. C., et al. (2012) · ACS Nano · doi:10.1021/nn301282m · Cited by 840
Dixon, L. J., Barnes, M., Tang, H., Pritchard, M. T., & Nagy, L. E. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120026 · Cited by 628
Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles
Magdolenova, Z., Collins, A., Kumar, A., Dhawan, A., Stone, V., & Dusinska, M. (2014) · Nanotoxicology · doi:10.3109/17435390.2013.773464 · Cited by 616
Inhaled Nanoparticles Accumulate at Sites of Vascular Disease
Miller, M. R., Raftis, J. B., Langrish, J. P., McLean, S. G., Samutrtai, P., Connell, S. P., Wilson, S., Vesey, A. T., Fokkens, P. H. B., Boere, A. J. F., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b08551 · Cited by 609
BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammals
Poser, I., Sarov, M., Hutchins, J. R. A., Hériché, J.-K., Toyoda, Y., Pozniakovsky, A., Weigl, D., Nitzsche, A., Hegemann, B., Bird, A. W., et al. (2008) · Nature Methods · doi:10.1038/nmeth.1199 · Cited by 603
Hirn, S., Semmler-Behnke, M., Schleh, C., Wenk, A., Lipka, J., Schäffler, M., Takenaka, S., Möller, W., Schmid, G., Simon, U., et al. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.029 · Cited by 583
Nanotoxicity: An Interplay of Oxidative Stress, Inflammation and Cell Death
Khanna, P., Ong, C., Bay, B., & Baeg, G. (2015) · Nanomaterials · doi:10.3390/nano5031163 · Cited by 580
Balasubramanian, S. K., Jittiwat, J., Manikandan, J., Ong, C.-N., Yu, L. E., & Ong, W.-Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.079 · Cited by 522
The evolutionary consequences of erroneous protein synthesis
Allan Drummond, D., & Wilke, C. O. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2662 · Cited by 515
Role of Kupffer cells in the pathogenesis of liver disease
Kolios, G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i46.7413 · Cited by 505
Role of oxidative damage in toxicity of particulates
Møller, P., Jacobsen, N. R., Folkmann, J. K., Danielsen, P. H., Mikkelsen, L., Hemmingsen, J. G., Vesterdal, L. K., Forchhammer, L., Wallin, H., & Loft, S. (2010) · Free Radical Research · doi:10.3109/10715760903300691 · Cited by 453
Huang, S., Strong, J. M., Zhang, L., Reynolds, K. S., Nallani, S., Temple, R., Abraham, S., Habet, S. A., Baweja, R. K., Burckart, G. J., et al. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007312153 · Cited by 396
Adverse outcome pathways: opportunities, limitations and open questions
Leist, M., Ghallab, A., Graepel, R., Marchan, R., Hassan, R., Bennekou, S. H., Limonciel, A., Vinken, M., Schildknecht, S., Waldmann, T., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2045-3 · Cited by 394
Nanomaterials Versus Ambient Ultrafine Particles: An Opportunity to Exchange Toxicology Knowledge
Stone, V., Miller, M. R., Clift, M. J. D., Elder, A., Mills, N. L., Møller, P., Schins, R. P. F., Vogel, U., Kreyling, W. G., Alstrup Jensen, K., et al. (2017) · Environmental Health Perspectives · doi:10.1289/ehp424 · Cited by 370
Ramaiahgari, S. C., den Braver, M. W., Herpers, B., Terpstra, V., Commandeur, J. N. M., van de Water, B., & Price, L. S. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1215-9 · Cited by 364
Self-citationGuo, L., Dial, S., Shi, L., Branham, W., Liu, J., Fang, J.-L., Green, B., Deng, H., Kaput, J., & Ning, B. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035873 · Cited by 348
Gold nanoparticles: Distribution, bioaccumulation and toxicity. In vitro and in vivo studies
Lopez-Chaves, C., Soto-Alvaredo, J., Montes-Bayon, M., Bettmer, J., Llopis, J., & Sanchez-Gonzalez, C. (2018) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2017.08.011 · Cited by 348
Update in global trends and aetiology of hepatocellular carcinoma
Rawla, P., Sunkara, T., Muralidharan, P., & Raj, J. P. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.78941 · Cited by 332
Role of the Kupffer Cell in Mediating Hepatic Toxicity and Carcinogenesis
Roberts, R. A., Ganey, P. E., Ju, C., Kamendulis, L. M., Rusyn, I., & Klaunig, J. E. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl173 · Cited by 331
Bell, C. C., Dankers, A. C. A., Lauschke, V. M., Sison-Young, R., Jenkins, R., Rowe, C., Goldring, C. E., Park, K., Regan, S. L., Walker, T., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfx289 · Cited by 327
Schleh, C., Semmler-Behnke, M., Lipka, J., Wenk, A., Hirn, S., Schäffler, M., Schmid, G., Simon, U., & Kreyling, W. G. (2012) · Nanotoxicology · doi:10.3109/17435390.2011.552811 · Cited by 325
Toxicity of Nano-Titanium Dioxide (TiO2-NP) Through Various Routes of Exposure: a Review
Shakeel, M., Jabeen, F., Shabbir, S., Asghar, M. S., Khan, M. S., & Chaudhry, A. S. (2016) · Biological Trace Element Research · doi:10.1007/s12011-015-0550-x · Cited by 320
Glicklis, R., Merchuk, J. C., & Cohen, S. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20086 · Cited by 316
Geraets, L., Oomen, A. G., Krystek, P., Jacobsen, N. R., Wallin, H., Laurentie, M., Verharen, H. W., Brandon, E. F., & de Jong, W. H. (2014) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-11-30 · Cited by 306
Hart, S. N., Li, Y., Nakamoto, K., Subileau, E.-A., Steen, D., & Zhong, X.-B. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.031831 · Cited by 296
Test No. 487: In Vitro Mammalian Cell Micronucleus Test
OECD (2023) · OECD Guidelines for the Testing of Chemicals, Section 4 · doi:10.1787/9789264264861-en · Cited by 279
Kostadinova, R., Boess, F., Applegate, D., Suter, L., Weiser, T., Singer, T., Naughton, B., & Roth, A. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.012 · Cited by 262
Curcio, E., Salerno, S., Barbieri, G., De Bartolo, L., Drioli, E., & Bader, A. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.033 · Cited by 261
Singh, S. (2019) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2018.1553221 · Cited by 251
Nanomaterial exposure, toxicity, and impact on human health
Pietroiusti, A., Stockmann‐Juvala, H., Lucaroni, F., & Savolainen, K. (2018) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1513 · Cited by 247
Oh, W.-K., Kim, S., Choi, M., Kim, C., Jeong, Y. S., Cho, B.-R., Hahn, J.-S., & Jang, J. (2010) · ACS Nano · doi:10.1021/nn100561e · Cited by 246
Halappanavar, S., van den Brule, S., Nymark, P., Gaté, L., Seidel, C., Valentino, S., Zhernovkov, V., Høgh Danielsen, P., De Vizcaya, A., Wolff, H., et al. (2020) · Particle and Fibre Toxicology · doi:10.1186/s12989-020-00344-4 · Cited by 246
Self-citationLi, C.-H., Shen, C.-C., Cheng, Y.-W., Huang, S.-H., Wu, C.-C., Kao, C.-C., Liao, J.-W., & Kang, J.-J. (2012) · Nanotoxicology · doi:10.3109/17435390.2011.620717 · Cited by 244
Lauschke, V. M., Hendriks, D. F. G., Bell, C. C., Andersson, T. B., & Ingelman-Sundberg, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00150 · Cited by 241
Ramakrishna, G., Rastogi, A., Trehanpati, N., Sen, B., Khosla, R., & Sarin, S. K. (2013) · Liver Cancer · doi:10.1159/000343852 · Cited by 238
3D Organotypic Cultures of Human HepaRG Cells: A Tool for In Vitro Toxicity Studies
Gunness, P., Mueller, D., Shevchenko, V., Heinzle, E., Ingelman-Sundberg, M., & Noor, F. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft021 · Cited by 236
Doak, S. H., Manshian, B., Jenkins, G. J. S., & Singh, N. (2012) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2011.09.013 · Cited by 234
Self-citationCell sources for in vitro human liver cell culture models
Zeilinger, K., Freyer, N., Damm, G., Seehofer, D., & Knöspel, F. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216657448 · Cited by 230
What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis
Iwaisako, K., Brenner, D. A., & Kisseleva, T. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07002.x · Cited by 219
Risk-based classification system of nanomaterials
Tervonen, T., Linkov, I., Figueira, J. R., Steevens, J., Chappell, M., & Merad, M. (2009) · Journal of Nanoparticle Research · doi:10.1007/s11051-008-9546-1 · Cited by 208
Kermanizadeh, A., Balharry, D., Wallin, H., Loft, S., & Møller, P. (2015) · Critical Reviews in Toxicology · doi:10.3109/10408444.2015.1058747 · Cited by 183
3D in vitro models of liver fibrosis
van Grunsven, L. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.004 · Cited by 175
Effects of Silver Nanoparticles on the Liver and Hepatocytes In Vitro
Gaiser, B. K., Hirn, S., Kermanizadeh, A., Kanase, N., Fytianos, K., Wenk, A., Haberl, N., Brunelli, A., Kreyling, W. G., & Stone, V. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kfs306 · Cited by 173
Agarwal, R., Jurney, P., Raythatha, M., Singh, V., Sreenivasan, S. V., Shi, L., & Roy, K. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500441 · Cited by 169
Han, J. W., Gurunathan, S., Jeong, J.-K., Choi, Y.-J., Kwon, D.-N., Park, J.-K., & Kim, J.-H. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-459 · Cited by 164
Singh, N., Jenkins, G. J. S., Nelson, B. C., Marquis, B. J., Maffeïs, T. G. G., Brown, A., Williams, P. M., Wright, C. J., & Doak, S. H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.087 · Cited by 162
Self-citationGenetics of Hepatobiliary Carcinogenesis
Nault, J.-C., & Zucman-Rossi, J. (2011) · Seminars in Liver Disease · doi:10.1055/s-0031-1276646 · Cited by 157
Liver-Kidney-on-Chip To Study Toxicity of Drug Metabolites
Theobald, J., Ghanem, A., Wallisch, P., Banaeiyan, A. A., Andrade-Navarro, M. A., Taškova, K., Haltmeier, M., Kurtz, A., Becker, H., Reuter, S., et al. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00417 · Cited by 157
O’Rourke, J. M., Sagar, V. M., Shah, T., & Shetty, S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i39.4436 · Cited by 156
The adverse outcome pathway: A multifaceted framework supporting 21st century toxicology
Ankley, G. T., & Edwards, S. W. (2018) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2018.03.004 · Cited by 155
Detection and characterization of mechanisms of action of aneugenic chemicals
Parry, E. M. (2002) · Mutagenesis · doi:10.1093/mutage/17.6.509 · Cited by 153
Lauschke, V. M., Shafagh, R. Z., Hendriks, D. F. G., & Ingelman‐Sundberg, M. (2019) · Biotechnology Journal · doi:10.1002/biot.201800347 · Cited by 153
Yan, X., Sedykh, A., Wang, W., Yan, B., & Zhu, H. (2020) · Nature Communications · doi:10.1038/s41467-020-16413-3 · Cited by 147
Nguyen, T. V., Ukairo, O. T., Khetani, S. R., McVay, M., Kanchagar, C., Seghezzi, W., Ayanoglu, G., Irrechukwu, O., & Evers, R. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.061317 · Cited by 140
p53: The Attractive Tumor Suppressor in the Cancer Research Field
Ozaki, T., & Nakagawara, A. (2011) · BioMed Research International · doi:10.1155/2011/603925 · Cited by 131
Can the comet assay be used reliably to detect nanoparticle‐induced genotoxicity?
Karlsson, H. L., Di Bucchianico, S., Collins, A. R., & Dusinska, M. (2015) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21933 · Cited by 124
A Cell-type-resolved Liver Proteome
Ding, C., Li, Y., Guo, F., Jiang, Y., Ying, W., Li, D., Yang, D., Xia, X., Liu, W., Zhao, Y., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.060145 · Cited by 124
Barabadi, H., Najafi, M., Samadian, H., Azarnezhad, A., Vahidi, H., Mahjoub, M. A., Koohiyan, M., & Ahmadi, A. (2019) · Medicina · doi:10.3390/medicina55080439 · Cited by 118
Genotoxicity Assessment of Nanomaterials: Recommendations on Best Practices, Assays, and Methods
Elespuru, R. K., Pfuhler, S., Aardema, M. J., Chen, T., Doak, S. H., Doherty, A., Farabaugh, C. S., Kenny, J. D., Manjanatha, M. G., Mahadevan, B., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy100 · Cited by 110
Self-citationSison-Young, R. L., Lauschke, V. M., Johann, E., Alexandre, E., Antherieu, S., Aerts, H., Gerets, H. H. J., Labbe, G., Hoët, D., Dorau, M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1745-4 · Cited by 104
The Adverse Outcome Pathway approach in nanotoxicology
Gerloff, K., Landesmann, B., Worth, A., Munn, S., Palosaari, T., & Whelan, M. (2017) · Computational Toxicology · doi:10.1016/j.comtox.2016.07.001 · Cited by 104
Hepato(Geno)Toxicity Assessment of Nanoparticles in a HepG2 Liver Spheroid Model
Elje, E., Mariussen, E., Moriones, O. H., Bastús, N. G., Puntes, V., Kohl, Y., Dušinská, M., & Rundén‐Pran, E. (2020) · Nanomaterials · doi:10.3390/nano10030545 · Cited by 104
Three-Dimensional HepaRG Model As An Attractive Tool for Toxicity Testing
Leite, S. B., Wilk-Zasadna, I., Zaldivar, J. M., Airola, E., Reis-Fernandes, M. A., Mennecozzi, M., Guguen-Guillouzo, C., Chesne, C., Guillou, C., Alves, P. M., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs232 · Cited by 103
Human health implications of nanomaterial exposure
Papp, T., Schiffmann, D., Weiss, D. G., Castranova, V., Vallyathan, V., & Rahman, Q. (2008) · Nanotoxicology · doi:10.1080/17435390701847935 · Cited by 103
A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies
Shah, U.-K., Mallia, J. D. O., Singh, N., Chapman, K. E., Doak, S. H., & Jenkins, G. J. S. (2017) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2017.12.005 · Cited by 103
Self-citationA Critical Review of in Vitro Dosimetry for Engineered Nanomaterials
Cohen, J. M., DeLoid, G. M., & Demokritou, P. (2015) · Nanomedicine · doi:10.2217/nnm.15.129 · Cited by 98
Thomas, D., Smith, J. N., Thrall, B. D., Baer, D. R., Jolley, H., Munusamy, P., Kodali, V., Demokritou, P., Cohen, J., & Teeguarden, J. (2018) · Particle and Fibre Toxicology · doi:10.1186/s12989-018-0243-7 · Cited by 98
Toll-Like Receptors in Liver Disease
Petrášek, J., Csák, T., & Szabó, G. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-405211-6.00006-1 · Cited by 94
Evans, S. J., Clift, M. J. D., Singh, N., de Oliveira Mallia, J., Burgum, M., Wills, J. W., Wilkinson, T. S., Jenkins, G. J. S., & Doak, S. H. (2017) · Mutagenesis · doi:10.1093/mutage/gew054 · Cited by 92
Self-citationKreyling, W. G., Holzwarth, U., Haberl, N., Kozempel, J., Hirn, S., Wenk, A., Schleh, C., Schäffler, M., Lipka, J., Semmler-Behnke, M., et al. (2017) · Nanotoxicology · doi:10.1080/17435390.2017.1306892 · Cited by 88
Zhao, J., Lu, H., Wong, S., Lu, M., Xiao, P., & Stenzel, M. H. (2017) · Polymer Chemistry · doi:10.1039/c7py00385d · Cited by 86
Mitochondrial dysfunctions trigger the calcium signaling-dependent fungal multidrug resistance
Li, Y., Zhang, Y., Zhang, C., Wang, H., Wei, X., Chen, P., & Lu, L. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911560116 · Cited by 86
Mandon, M., Huet, S., Dubreil, E., Fessard, V., & Le Hégarat, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-47114-7 · Cited by 84
Kermanizadeh, A., L hr, M., Roursgaard, M., Messner, S., Gunness, P., Kelm, J. M., Møller, P., Stone, V., & Loft, S. (2014) · Particle and Fibre Toxicology · doi:10.1186/s12989-014-0056-2 · Cited by 82
Scaffold‐Free Liver‐On‐A‐Chip with Multiscale Organotypic Cultures
Weng, Y., Chang, S., Shih, M., Tseng, S., & Lai, C. (2017) · Advanced Materials · doi:10.1002/adma.201701545 · Cited by 79
Wink, S., Hiemstra, S. W., Herpers, B., & van de Water, B. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1781-0 · Cited by 69
Kyffin, J. A., Sharma, P., Leedale, J., Colley, H. E., Murdoch, C., Mistry, P., & Webb, S. D. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.01.023 · Cited by 67
The comet assay applied to HepG2 liver spheroids
Elje, E., Hesler, M., Rundén-Pran, E., Mann, P., Mariussen, E., Wagner, S., Dusinska, M., & Kohl, Y. (2019) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2019.03.006 · Cited by 65
Toxicological effect of engineered nanomaterials on the liver
Kermanizadeh, A., Gaiser, B. K., Johnston, H. J., Brown, D. M., & Stone, V. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12421 · Cited by 62
Hégarat, L. L., Mourot, A., Huet, S., et al. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu004 · Cited by 62
Dumont, J., Jossé, R., Lambert, C. B., Anthérieu, S., Hégarat, L. L., Aninat, C., Robin, M., Guguen‐Guillouzo, C., & Guillouzo, A. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.03.008 · Cited by 59
Slow lung clearance and limited translocation of four sizes of inhaled iridium nanoparticles
Buckley, A. J., Warren, J., Hodgson, A., Marczylo, T. H., Ignatyev, K., Guo, C., & Smith, R. (2017) · Particle and Fibre Toxicology · doi:10.1186/s12989-017-0185-5 · Cited by 59
Atienzar, F., Novik, E., Gerets, H. H. J., Parekh, A., Delatour, C., Cardenas, A., MacDonald, J. S., Yarmush, M. L., & Dhalluin, S. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.11.022 · Cited by 58
Higuchi, Y., Kawai, K., Kanaki, T., Yamazaki, H., Chesné, C., Guguen‐Guillouzo, C., & Suemizu, H. (2016) · Hepatology Research · doi:10.1111/hepr.12644 · Cited by 58
Dubiak-Szepietowska, M., Karczmarczyk, A., Jönsson‐Niedziółka, M., Winckler, T., & Feller, K. ‐. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.01.016 · Cited by 58
Wills, J. W., Summers, H. D., Hondow, N., Sooresh, A., Meissner, K. E., White, P. A., Rees, P. C. T., Brown, A., & Doak, S. H. (2017) · ACS Nano · doi:10.1021/acsnano.7b03708 · Cited by 58
Self-citationHiemstra, S., Ramaiahgari, S. C., Wink, S., Callegaro, G., Coonen, M., Meerman, J., Jennen, D., van den Nieuwendijk, K., Dankers, A., Snoeys, J., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02552-0 · Cited by 53
Self-citationConway, G. E., Shah, U.-K., Llewellyn, S. V., Červená, T., Evans, S. J., Ali, A., Jenkins, G. J. S., Clift, M. J. D., & Doak, S. H. (2020) · Mutagenesis · doi:10.1093/mutage/geaa018 · Cited by 52
Self-citationPark, K., Park, J., Lee, H., Choi, J. Y., Yu, W., & Lee, J. S. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1074-7 · Cited by 48
Ramaiahgari, S. C., Waidyanatha, S., Dixon, D., DeVito, M. J., Paules, R. S., & Ferguson, S. S. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx194 · Cited by 44
Han, S., Han, L., Yao, Y., Sun, H., ZAN, X., & Liu, Q. (2013) · Oncology Reports · doi:10.3892/or.2013.2872 · Cited by 41
Improvements in the reliability ofin vitrogenotoxicity testing
Kirkland, D. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.627855 · Cited by 35
Kermanizadeh, A., Brown, D. M., Moritz, W., & Stone, V. (2019) · Scientific Reports · doi:10.1038/s41598-019-43870-8 · Cited by 33
Genotoxic risk of ethyl‐paraben could be related to telomere shortening
Finot, F., Kaddour, A., Morat, L., Mouche, I., Zaguia, N., Cuceu, C., Souverville, D., Négrault, S., Cariou, O., Essahli, A., et al. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3425 · Cited by 31
Hiemstra, S. W., Niemeijer, M., Koedoot, E., Wink, S., Klip, J. E., Vlasveld, M., de Zeeuw, E., van Os, B. W., White, A., & van de Water, B. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00322 · Cited by 31
Self-citationAn Update on Adverse Outcome Pathways Leading to Liver Injury
Gijbels, E., & Vinken, M. (2017) · Applied In Vitro Toxicology · doi:10.1089/aivt.2017.0027 · Cited by 30
Structure, Function, and Responses to Injury
Crawford, J. M., Bioulac‐Sage, P., & Hytiroglou, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00001-7 · Cited by 29
Kermanizadeh, A., Berthing, T., Guzniczak, E., Wheeldon, M., Whyte, G., Vogel, U. B., Moritz, W., & Stone, V. (2019) · Particle and Fibre Toxicology · doi:10.1186/s12989-019-0326-0 · Cited by 28
Distribution of SiO2 nanoparticles in 3D liver microtissues
Fleddermann, J., Susewind, J., Peuschel, H., Koch, M., Tavernaro, I., & Kraegeloh, A. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s189888 · Cited by 27
The Role Of Hepatic Stellate Cells In Promoting Liver Metastasis Of Colorectal Carcinoma
Huang, W., Zhou, M., Zhu, Y., Xiang, J., Li, Z., Wang, Z.-H., Zhou, Y., Yang, Y., Chen, Z., & Gu, X. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s214409 · Cited by 23
Differential fibrotic phenotypes of hepatic stellate cells within 3D liver organoids
Brovold, M., Keller, D., & Soker, S. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27379 · Cited by 21
Costa, S., & Teixeira, J. P. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386454-3.01072-1 · Cited by 13
Studying the Oxidative Stress Paradigm In Vitro: A Theoretical and Practical Perspective
Clift, M. J. D., & Rothen‐Rutishauser, B. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-475-3_7 · Cited by 9
Systems Microscopy Approaches in Unraveling and Predicting Drug-Induced Liver Injury (DILI)
Niemeijer, M., Hiemstra, S. W., Wink, S., den Hollander, W., ter Braak, B., & van de Water, B. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_29 · Cited by 7
Self-citationBiomaterial Control of Therapeutic Stem Cells
Higuchi, A. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788012690 · Cited by 4
Research works printed but not linked: 7
- Hardy A., 2018, EFSA J., 16, 5327
- Modrzynska J., 2018, Toxicological Effects of Nanoparticle Deposition in the Liver
- Bahadar H., 2016, Iran. Biomed. J., 20, 1
- Nguyen‐Lefebvre A. T., 2015, Enzymol. Metab. J., 1, 101
- Nakagawara A., 2011, J. Biomed. Biotechnol., 2011, 603925
- Ramaiahgari S. C., 2014, Arch. Toxicol., 88, 1083
- Llewellyn S. V., 2020, J. Visualized Exp., 160, e61141
Cited by
Constructing biomimetic microenvironments for liver regeneration
(2025) · doi:10.1186/s12951-025-03729-9 · Cited by 11
Metadata
- Authors
- Llewellyn, S. V., Niemeijer, M., Nymark, P., Moné, M. J., van de Water, B., Conway, G. E., Jenkins, G. J. S., & Doak, S. H.
- Affiliations
- Swansea University (GB)
- Leiden University (NL)
- Karolinska Institutet (SE)
- Division of Drug Discovery and Safety Leiden Academic Centre for Drug Research Leiden University Einsteinweg 55 Leiden 2333 CC The Netherlands
- Corresponding author
- Doak, Shareen H.
- ORCID
- Venue
- Small
- Publisher
- Wiley
- Published
- 2021-01-15
- Volume
- 17
- Issue
- 15
- Pages
- e2006055-e2006055
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W3122809306
- Cited by
- 41
- References
- 116
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 12 · 2023: 5 · 2022: 9 · 2021: 3
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Small (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Leiden Repository (Leiden University) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
- Funders
- European Commission (760813, HORIZON2020, 681002)
- National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC/R001375/1)
- Universiteit Leiden
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
- Physical Sciences › Engineering › Biomedical Engineering › Graphene and Nanomaterials Applications
- Keywords
- engineered nanomaterials, genotoxicity, DNA damage, hepatocyte spheroids, nanotoxicology, chronic liver disease, DNA repair, repeated exposure, in vitro toxicity testing, health risk assessment
- MeSH terms
- DNA Damage, Humans, Liver, Risk Assessment, Nanostructures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.